255 related articles for article (PubMed ID: 17504155)
1. The bright future of radionuclides for cancer therapy.
Nijsen JF; Krijger GC; van Het Schip AD
Anticancer Agents Med Chem; 2007 May; 7(3):271-90. PubMed ID: 17504155
[TBL] [Abstract][Full Text] [Related]
2. Which radionuclides will nuclear oncology need tomorrow?
Barbet J; Chatal JF; Gauché F; Martino J
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):627-30. PubMed ID: 16741760
[No Abstract] [Full Text] [Related]
3. [Radiation biology. Knowledge combines nuclear medicine and radiation oncology].
Kotzerke J; Baumann M
Nuklearmedizin; 2010; 49 Suppl 1():S1-2. PubMed ID: 21152685
[No Abstract] [Full Text] [Related]
4. The role of radioisotopes in radiation oncology.
Park CH
Semin Oncol; 1997 Dec; 24(6):639-54. PubMed ID: 9422261
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic radionuclides in nuclear medicine: current and future prospects.
Yeong CH; Cheng MH; Ng KH
J Zhejiang Univ Sci B; 2014 Oct; 15(10):845-63. PubMed ID: 25294374
[TBL] [Abstract][Full Text] [Related]
6. Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities?
Valdés Olmos RA; Hoefnagel CA
Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):929-31. PubMed ID: 15042326
[No Abstract] [Full Text] [Related]
7. Radiopharmaceuticals in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A position paper from the International Society of Geriatric Oncology Task Force.
Prior JO; Gillessen S; Wirth M; Dale W; Aapro M; Oyen WJG
Eur J Cancer; 2017 May; 77():127-139. PubMed ID: 28391026
[TBL] [Abstract][Full Text] [Related]
8. Is there life after technetium: what is the potential for developing new broad-based radionuclides?
Srivastava SC
Semin Nucl Med; 1996 Apr; 26(2):119-31. PubMed ID: 8723506
[TBL] [Abstract][Full Text] [Related]
9. Targeted α-Therapy.
Brechbiel MW
Cancer Biother Radiopharm; 2020 Aug; 35(6):397. PubMed ID: 32503377
[No Abstract] [Full Text] [Related]
10. Transforming Nuclear Medicine with Nanoradiopharmaceuticals.
Roy I; Krishnan S; Kabashin AV; Zavestovskaya IN; Prasad PN
ACS Nano; 2022 Apr; 16(4):5036-5061. PubMed ID: 35294165
[TBL] [Abstract][Full Text] [Related]
11. Clinical Radioimmunotherapy and Systemic Targeted Radiopharmaceutical Therapy (STaRT) programs in a radiation oncology environment.
Macklis RM
Am J Clin Oncol; 2006 Dec; 29(6):543-7. PubMed ID: 17148988
[No Abstract] [Full Text] [Related]
12. Current applications and perspectives of diagnostic nuclear medicine in oncology. Task Group of Oncology.
Bombardieri E; Carrio I; Gonzalez P; Serafini A; Turner JH; Virgolini I; Maffioli L
Int J Oncol; 1999 May; 14(5):877-90. PubMed ID: 10200337
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy in nuclear medicine--current status and future prospects.
Oyen WJ; Bodei L; Giammarile F; Maecke HR; Tennvall J; Luster M; Brans B
Ann Oncol; 2007 Nov; 18(11):1782-92. PubMed ID: 17434893
[TBL] [Abstract][Full Text] [Related]
14. Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy.
Ting G; Chang CH; Wang HE
Anticancer Res; 2009 Oct; 29(10):4107-18. PubMed ID: 19846958
[TBL] [Abstract][Full Text] [Related]
15. Advances in cancer therapy with radiolabeled monoclonal antibodies.
Goldenberg DM; Sharkey RM
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):248-64. PubMed ID: 17043623
[TBL] [Abstract][Full Text] [Related]
16. [Application of radiometallic compounds for medical diagnosis and therapy].
Saji H
Yakugaku Zasshi; 2008 Mar; 128(3):323-32. PubMed ID: 18311050
[TBL] [Abstract][Full Text] [Related]
17. Targeted radionuclide therapy--an overview.
Dash A; Knapp FF; Pillai MR
Curr Radiopharm; 2013 Sep; 6(3):152-80. PubMed ID: 24059327
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Separation of nuclear isomers for cancer therapeutic radionuclides based on nuclear decay after-effects.
Bhardwaj R; van der Meer A; Das SK; de Bruin M; Gascon J; Wolterbeek HT; Denkova AG; Serra-Crespo P
Sci Rep; 2017 Mar; 7():44242. PubMed ID: 28287131
[No Abstract] [Full Text] [Related]
20. Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran.
Jalilian AR; Beiki D; Hassanzadeh-Rad A; Eftekhari A; Geramifar P; Eftekhari M
Semin Nucl Med; 2016 Jul; 46(4):340-58. PubMed ID: 27237443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
